Drug Pipeline Insights Report
Fast action for postpartum depression
New drugs for postpartum depression, dermatitis and blindness are coming.
New drugs focus on recent therapies for larger patient populations
Welcome to the next issue of Drugs to Watch for 2023
In this Drug Pipeline Insights Report, we review:
- Fast-acting treatment for postpartum depression
- The first treatment approved to prevent blindness due to geographic atrophy
- Relief from moderate-to-severe atopic dermatitis
Don't want to read the full report? Download the brief summary.
Related Content
3 new first-in-class therapies coming
See how innovation is driving the latest product development.
Rules impacting pharmacy: Summer 2023 legislative sessions
Learn what's at stake as the Senate considers PBM legislation.
4 new drugs to watch this year
Breakthrough treatments for menopause, Alzheimer's and hemophilia are coming.
Top